Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$6.00 0.16 | 2.74%

05/17/13 - 04:00 PM ET

Company Income Statement

Preferred Dividends
	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Sales	1.48M	803.00K	13.51M	46.51M
Cost of Sales	0.00	0.00	0.00	-1.34M
Gross Operating Profit	1.48M	803.00K	13.51M	47.86M
Selling, General, and Administrative Expenses	20.13M	7.93M	5.08M	4.65M
Research & Development	23.52M	30.63M	35.15M	29.26M
Operating Income before D & A (EBITDA)	-42.17M	-37.75M	-26.72M	13.95M
Depreciation & Amortization	1.20M	1.10M	1.46M	1.34M
Interest Income	120.00K	31.00K	107.00K	514.33K
Other Income - Net	-660.00K	117.00K	542.00K	0.00
Special Income / Charges	0.00	0.00	0.00	0.00
Total Income Before Interest Expenses (EBIT)	-43.91M	-38.70M	-27.53M	13.12M
Interest Expense	3.58M	1.87M	12.39M	12.66M
Pre-Tax Income	-47.48M	-40.57M	-39.92M	460.24K
Income Taxes	0.00	-16.24M	0.00	0.00
Minority Interest	0.00	0.00	0.00	0.00
Net Income From Continuing Operations	-46.28M	-23.22M	-38.46M	460.24K
Net Income From Discontinued Operations	0.00	77.04M	0.00	0.00
Net Income From Total Operations	-46.28M	53.82M	-38.46M	460.24K
Extraordinary Income/Losses	0.00	0.00	0.00	0.00
Income From Cum. Effect of Acct. Change	0.00	0.00	0.00	0.00
Income From Tax Loss Carryforward	0.00	0.00	0.00	0.00
Other Gains / Losses	0.00	0.00	0.00	0.00
Total Net Income	-46.28M	53.82M	-38.46M	460.24K
Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge)	-46.28M	-23.22M	-38.46M	460.24K
Net Income Available To Common	-47.43M	-26.66M	-41.89M	-2.97M
Basic EPS from Continuing Ops.	-2.72	-1.68	0.00	0.00
Basic EPS from Discontinued Ops.	0.00	5.56	0.00	0.00
Basic EPS from Total Operations	-2.72	3.88	0.00	0.00
Basic EPS from Extraordinary Inc.	0.00	0.00	0.00	0.00
Basic EPS from Cum Effect of Accounting Change	0.00	0.00	0.00	0.00
Basic EPS from Tax Loss Carryf'd.	0.00	0.00	0.00	0.00
Basic EPS from Other Gains (Losses)	0.00	0.00	0.00	0.00
Basic EPS, Total	-2.72	3.88	0.00	0.00
Basic Normalized Net Income/Share	-2.72	-1.68	n.a.	n.a.
EPS fr Continuing Ops.	-2.72	-1.68	0.00	0.00
EPS fr Discontinued Ops	0.00	5.56	0.00	0.00
EPS fr Total Ops.	-2.72	3.88	0.00	0.00
EPS fr Extraord. Inc.	0.00	0.00	0.00	0.00
EPS fr Cum Effect of Accounting Change	0.00	0.00	0.00	0.00
EPS fr Tax Loss Carfd.	0.00	0.00	0.00	0.00
EPS fr Other Gains (L)	0.00	0.00	0.00	0.00
EPS, Total	-2.72	3.88	0.00	0.00
Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge)	-2.72	-1.68	n.a.	n.a.
Dividends Paid per Share	0.00	0.00	0.00	0.00